Corneal deposits after topical tosufloxacin in a patient with poor tear secretion

Cornea

Volumn 28, Issue 1, 2009, Pages 114-115

  Kamiya, Kazutaka ^a   Kitahara, Miyuki ^a   Shimizu, Kimiya ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corneal deposits; Infrared spectrophotometry; Side effect; Tosufloxacin

Indexed keywords

BETAMETHASONE; DICLOD; DICLOFENAC; HYALEIN; HYALURONIC ACID; LEVOFLOXACIN; TOSUFLOXACIN; TOSUFLOXACIN TOSILATE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; NAPHTHYRIDINE DERIVATIVE; QUINOLONE DERIVATIVE;

AGED; ARTICLE; BLURRED VISION; CASE REPORT; CATARACT EXTRACTION; CLINICAL FEATURE; CORNEA EROSION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; KERATECTOMY; LACRIMATION DISORDER; LENS IMPLANTATION; PHACOEMULSIFICATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; SCHIRMER TEST; SLIT LAMP; SOFT CONTACT LENS; SPECTACLES; VISUAL ACUITY; CHEMICALLY INDUCED DISORDER; CORNEA DISEASE; LACRIMAL FLUID; METABOLISM; PATHOLOGY; POSTOPERATIVE COMPLICATION; SECRETION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CATARACT EXTRACTION; CORNEAL DISEASES; FEMALE; FLUOROQUINOLONES; HUMANS; NAPHTHYRIDINES; POSTOPERATIVE COMPLICATIONS; TEARS;

EID: 62149097647     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181822667     Document Type: Article

References (12)

1. Yamaguchi K. Evaluation of in-vitro and in-vivo antibacterial activity of tosufloxacin tosilate. J Infect Chemother. 2001;7:205-217.
2. Niki Y. Pharmacokinetics and safety assessment of tosufloxacin tosilate. J Infect Chemother. 2002;8:1-18.
3. Kohno S. Clinical assessment of tosufloxacin tosilate. J Infect Chemother. 2002;8:19-27.
4. Owens RC Jr, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005;41:S144-S157.
5. Takahama H, Tazaki H. Tosufloxacin tosilate-induced thrombocytopenic purpura. J Dermatol. 2007;34:465-467.
6. Madhavan HN, Rao SK, Joseph PR, et al. Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution. Cornea. 1999;18:549-552.
7. Essepian JP, Rajpal R, O'Brien TP. Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo. Cornea. 1995;14:402-407.
8. Eiferman RA, Snyder JP, Nordquist RE. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. J Cataract Refract Surg. 2001;27:1701-1702.
9. Wilhelmus KR, Abshire RL. Corneal ciprofloxacin precipitation during bacterial keratitis. Am J Ophthalmol. 2003;136:1032-1037.
10. Castillo A, Benitez del Castillo JM, et al. Deposits of topical norfloxacin in the treatment of bacterial keratitis. Cornea. 1997;16:420-423.
11. Konishi M, Yamada M, Mashima Y. Corneal ulcer associated with deposits of norfloxacin. Am J Ophthalmol. 1998;125:258-260.
12. Sinnaeve BA, Decaestecker TN, Claerhout IJ, et al. Confirmation of ofloxacin precipitation in corneal deposits by microbore liquid chromatography-quadrupole time-of-flight tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;785:193-196.